$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Exicure, Inc.
Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
Sector
Commercial Services
CEO
David A. Giljohann
Industry
Miscellaneous Commercial Services
Exchange
NASDAQ
Website
Top Stories
Coming soon.